Hyperfine (HYPR) versus Its Peers Head to Head Contrast

Hyperfine (NASDAQ:HYPRGet Rating) is one of 69 public companies in the “Electromedical equipment” industry, but how does it compare to its competitors? We will compare Hyperfine to related businesses based on the strength of its valuation, dividends, earnings, risk, analyst recommendations, institutional ownership and profitability.

Earnings & Valuation

This table compares Hyperfine and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Hyperfine $1.50 million -$64.85 million -0.20
Hyperfine Competitors $1.03 billion $130.62 million 0.62

Hyperfine’s competitors have higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

23.9% of Hyperfine shares are owned by institutional investors. Comparatively, 44.7% of shares of all “Electromedical equipment” companies are owned by institutional investors. 26.1% of Hyperfine shares are owned by company insiders. Comparatively, 11.3% of shares of all “Electromedical equipment” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Hyperfine and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperfine 0 1 2 0 2.67
Hyperfine Competitors 89 598 1655 77 2.71

Hyperfine currently has a consensus price target of $4.30, indicating a potential upside of 491.47%. As a group, “Electromedical equipment” companies have a potential upside of 86.20%. Given Hyperfine’s higher probable upside, equities analysts plainly believe Hyperfine is more favorable than its competitors.


This table compares Hyperfine and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Hyperfine -1,479.40% -54.01% -49.87%
Hyperfine Competitors -694.90% -44.28% -25.30%

Risk and Volatility

Hyperfine has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, Hyperfine’s competitors have a beta of 13.35, suggesting that their average stock price is 1,235% more volatile than the S&P 500.


Hyperfine competitors beat Hyperfine on 11 of the 13 factors compared.

About Hyperfine

(Get Rating)

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.